LAM Treatment Alliance Fast Tracking Treatment Research

LAM is a disease that kills women from all races, classes and countries -- primarily while in their child bearing years. It affects the lungs, kidneys, lymphatic system, and at times the brain. There is no known cure, but we are working hard to find one. Learn More About LAM

Patient & Clinician Resources
Understanding LAM
Living with LAM
Treating LAM
LAM Science
Learn
Participate
LAM TV
LAM TV
About LTA
About the LAM Treatment Alliance
News and Updates
News and Updates
How You Can Help
How you can help
DONATE

Past Seminars

Upcoming Seminars

The seminar series will return in the fall

This year's Seminar Series and your active support enabled us to increase our impact in the fight to treat and cure LAM. These monthly meetings have showcased and advanced work we are supporting to leverage breakthrough microchip technology for detection and capture of circulating cells, to discover the whole story behind LAM genetics most thoroughly and quickly and to carefully consider the pros and cons related to treatment focused on hormonal modulation in LAM, the role of leading-edge work in lung regeneration, the use of zebrafish and other models to accelerate therapeutic development and the identification of additional druggable targets for the disease related to defective cell signaling.

Thanks to you, we have accomplished so much, so fast. Thank you for your presentations and for your engaged and rigorous participation in person or remotely via live webcast. Our Seminar Series continues to be THE regular LAM Community meeting ground and touch point for vetting leading-edge thinking about LAM and TSC. Click here to see the 2009-2010 YEAR IN PHOTOS!

We offer heartfelt thanks to David Kwiatkowski, the HMS Department of Genetics, Department of Continuing Medical Education, Terri Broderick, Suzanne Clewley and Kenji Kono, Richard Abrusci and all LAM Treatment Alliance staff and volunteers, LAM patients and their families, Lisa Henske and the BWH Center for LAM Research and Clinical Care, the TS Alliance, Bertucci's, and Alipes CME for your expertise, generosity and solidarity throughout.

Thank you for participating in our year-end survey! Your feedback will help us to increase our impact. We congratulate Nicole Neuman, PhD, the winner of our $25 Starbucks giftcard in our raffle!

Thank you so much for making our cause, your cause! Onward!

Overview: LAM occurs in association with various extrapulmonary manifestations. Although pelvic diseases have been described in patients with LAM previously, the relationship between LAM and uterine leiomyoma is not well understood. It seems reasonable to explore a relationship between LAM and uterine leiomyoma in that both diseases are sex specific and hormone dependent and uterine leiomyoma tend to develop, like LAM, during reproductive years. In one rare sub-type, the lung is the most affected extra-uterine organ. During this important session focused on this topic, we bring together leaders in this field to provide insight into links between the two diseases. Please join us as an active participant in this dialogue as we consider evidence and critical next steps.
RSVP: RSVP is required to attend meetings. Please register here or send an email to amy_farber@hms.harvard.edu and indicate the names and total number of people attending from your department or lab.

Live Webcast: Live streaming of our monthly LAM/TSC Seminar Series is available. To obtain a password, please contact ltaadmin@lamtreatmentalliance.org .

Location: Seminars are held in room #350 in the New Research Building (NRB) at Harvard Medical School in Boston, Massachusetts, USA 02115.

Parking: Free parking in the lot below the New Research Building has been graciously donated. Space is limited and will be made available to participants coming from outside of the Longwood Medical Area if requested by May 26th at 10am EST.